Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127737181 | 12773718 | 1 | I | 20160614 | 20160923 | 20160923 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023454 | GLENMARK | JACOBSEN A, PAPO Y, SARRO R, WEISSE K, STRASSWIMMER J.. POSACONAZOLE SUBSTITUTION FOR VORICONAZOLE-ASSOCIATED PHOTOCARCINOGENESIS.. 2016 ANNUAL MEETING OF THE SOCIETY FOR INVESTIGATIVE DERMATOLOGY, SID 2016. 2016;136(5 SUPPL.1):S103 | 0.00 | Y | 0.00000 | 20160923 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127737181 | 12773718 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | UNK | U | 203503 | |||||||||
127737181 | 12773718 | 2 | C | CORTICOSTEROIDS | CORTICOSTEROID NOS | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127737181 | 12773718 | 1 | Meningitis |
127737181 | 12773718 | 2 | Meningitis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127737181 | 12773718 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127737181 | 12773718 | Actinic keratosis | |
127737181 | 12773718 | Photosensitivity reaction | |
127737181 | 12773718 | Product use issue | |
127737181 | 12773718 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |